JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.22B |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$1.55B |
| 3 |
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
|
+$1.31B |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.1B |
| 5 |
Wells Fargo
WFC
|
+$899M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.46B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.45B |
| 3 |
Tesla
TSLA
|
+$2.03B |
| 4 |
TSMC
TSM
|
+$1.66B |
| 5 |
Texas Instruments
TXN
|
+$1.62B |
Sector Composition
| 1 | Technology | 18.09% |
| 2 | Financials | 11.43% |
| 3 | Consumer Discretionary | 11.01% |
| 4 | Healthcare | 10.73% |
| 5 | Industrials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3951
PAVmed
PAVM
$9.65M
| $213K | ﹤0.01% |
6,714
+4,967
| +284% | +$158K |
|
3952
Dynavax Technologies
DVAX
$1.14B
| $212K | ﹤0.01% |
47,828
+8,219
| +21% | +$36.4K |
|
3953
Evolus
EOLS
$407M
| $212K | ﹤0.01% |
63,134
+54,981
| +674% | +$185K |
|
3954
Universal Technical Institute
UTI
$1.54B
| $212K | ﹤0.01% |
32,776
+22,019
| +205% | +$142K |
|
3955
Kiniksa Pharmaceuticals
KNSA
$2.62B
| $210K | ﹤0.01% |
11,885
+1,920
| +19% | +$33.9K |
|
3956
Lindblad Expeditions
LIND
$711M
| $209K | ﹤0.01% |
12,239
+1,657
| +16% | +$28.3K |
|
3957
Aquestive Therapeutics
AQST
$686M
| $208K | ﹤0.01% |
38,863
+25,347
| +188% | +$136K |
|
|
BCEL
3958
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $207K | ﹤0.01% |
12,808
+2,312
| +22% | +$37.4K |
|
3959
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.07B
| $206K | ﹤0.01% |
3,122
+2,122
| +212% | +$140K |
|
3960
Neurogene
NGNE
$245M
| $205K | ﹤0.01% |
726
+116
| +19% | +$32.8K |
|
3961
OptimizeRx
OPRX
$338M
| $205K | ﹤0.01% |
6,578
+1,147
| +21% | +$35.7K |
|
3962
Invesco S&P 500 Pure Value ETF
RPV
$1.36B
| $205K | ﹤0.01% |
3,330
-32
| -1% | -$1.97K |
|
|
ADMS
3963
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $205K | ﹤0.01% |
47,366
+7,131
| +18% | +$30.9K |
|
3964
Champions Oncology
CSBR
$90.5M
| $203K | ﹤0.01% |
18,827
+7,687
| +69% | +$82.9K |
|
3965
Geron
GERN
$842M
| $203K | ﹤0.01% |
127,842
+20,743
| +19% | +$32.9K |
|
|
SWCH
3966
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $203K | ﹤0.01% |
12,372
-251,959
| -95% | -$4.13M |
|
3967
Electromed
ELMD
$207M
| $202K | ﹤0.01% |
20,551
+8,351
| +68% | +$82.1K |
|
3968
Safe Bulkers
SB
$464M
| $202K | ﹤0.01% |
155,103
+105,363
| +212% | +$137K |
|
|
AFIB
3969
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $201K | ﹤0.01% |
6,974
+3,108
| +80% | +$89.6K |
|
|
VIEWW
3970
DELISTED
View, Inc. Warrant
VIEWW
| – | – |
0
| – | – |
|
|
TGA
3971
DELISTED
Transglobe Energy Corp
TGA
| $201K | ﹤0.01% |
208,800
+4,100
| +2% | +$3.95K |
|
3972
Research Frontiers
REFR
$48.1M
| $200K | ﹤0.01% |
71,028
+61,137
| +618% | +$172K |
|
|
AGFS
3973
DELISTED
AgroFresh Solutions, Inc. Common Stock
AGFS
| $198K | ﹤0.01% |
87,001
+56,249
| +183% | +$128K |
|
3974
iShares US Industrials ETF
IYJ
$1.68B
| $195K | ﹤0.01% |
2,005
+1,361
| +211% | +$132K |
|
3975
abrdn Physical Silver Shares ETF
SIVR
$2.69B
| $195K | ﹤0.01% |
7,634
-8,508
| -53% | -$217K |
|